| 000 | 01594 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514182408.0 | ||
| 264 | 0 | _c20041207 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0026-2862 | ||
| 024 | 7 |
_a10.1016/j.mvr.2003.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoriuchi, Yoshihito | |
| 245 | 0 | 0 |
_aRole of histamine release in nonspecific vasodilatation during anodal and cathodal iontophoresis. _h[electronic resource] |
| 260 |
_bMicrovascular research _cMar 2004 |
||
| 300 |
_a192-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnesthetics, Local _xpharmacology |
| 650 | 0 | 4 |
_aCetirizine _xpharmacology |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists, Non-Sedating _xpharmacology |
| 650 | 0 | 4 |
_aHistamine Release _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIontophoresis _xmethods |
| 650 | 0 | 4 |
_aLidocaine _xpharmacology |
| 650 | 0 | 4 | _aLidocaine, Prilocaine Drug Combination |
| 650 | 0 | 4 |
_aNeurons, Afferent _xdrug effects |
| 650 | 0 | 4 |
_aPrilocaine _xpharmacology |
| 650 | 0 | 4 |
_aSodium Chloride _xadministration & dosage |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aDroog, Erik J | |
| 700 | 1 | _aHenricson, Joakim | |
| 700 | 1 | _aWikström, Thore | |
| 700 | 1 | _aLennquist, Sten | |
| 700 | 1 | _aSjöberg, Folke | |
| 773 | 0 |
_tMicrovascular research _gvol. 67 _gno. 2 _gp. 192-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mvr.2003.12.002 _zAvailable from publisher's website |
| 999 |
_c14739589 _d14739589 |
||